Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Zetterberg H"" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 21707
Tytuł:
Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer’s Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project
Autorzy:
Malzbender, K.
Barbarino, P.
Ferrell, P. Barkman
Bradshaw, A.
Brookes, A. J.
Díaz, C.
van der Flier, W. M.Aff7, Aff8, Aff9
Georges, J.
Hansson, O.Aff10, Aff11
Hartmanis, M.
Jönsson, L.
Krishnan, R.
MacLeod, T.
Mangialasche, F.Aff13, Aff14
Mecocci, P.Aff13, Aff15
Minguillon, C.Aff16, Aff17, Aff18
Middleton, L.Aff19, Aff20
Pla, S.
Sardi, S. P.
Schöll, M.Aff21, Aff22, Aff23
Suárez-Calvet, M.Aff16, Aff17, Aff18, Aff24
Weidner, W.
Visser, P. J.Aff7, Aff13, Aff25
Zetterberg, H.Aff26, Aff27, Aff28, Aff29, Aff30, Aff31
Bose, N.
Solomon, A.Aff13, Aff19, Aff32
Kivipelto, MiiaAff12, Aff13, Aff14, Aff19, Aff33, Aff35, IDjpad202432_cor27
Pokaż więcej
Źródło:
The Journal of Prevention of Alzheimer's Disease. 11(2):329-338
Czasopismo naukowe
Szczegóły
Tytuł:
Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus
Autorzy:
Jeppsson, A.
Sandelius, Å.
Zettergren, A.
Kern, S.
Skoog, I.
Blennow, K.
Zetterberg, H.Aff2, Aff4, Aff5, Aff6, Aff7
Wikkelsø, C.
Hellström, P.
Tullberg, M.Aff1, IDs1298702300455y_cor10
Pokaż więcej
Źródło:
Fluids and Barriers of the CNS. 20(1)
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
Autorzy:
Leuzy, A.
Ashton, N. J.Aff2, Aff3, Aff4
Mattsson-Carlgren, N.Aff1, Aff5, Aff6
Dodich, A.Aff7, Aff8
Boccardi, M.Aff9, Aff10
Corre, J.
Drzezga, A.
Nordberg, A.Aff13, Aff14
Ossenkoppele, R.Aff1, Aff15
Zetterberg, H.Aff2, Aff16, Aff17, Aff18
Blennow, K.Aff2, Aff16
Frisoni, G. B.Aff9, Aff19
Garibotto, V.
Hansson, O.Aff1, Aff20
Pokaż więcej
Źródło:
European Journal of Nuclear Medicine and Molecular Imaging. 48(7):2121-2139
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers
Autorzy:
Ashton, N. J.Aff1, Aff2, Aff3, IDs0025902105253y_cor1
Leuzy, A.
Karikari, T. K.
Mattsson-Carlgren, N.Aff4, Aff5, Aff6
Dodich, A.Aff7, Aff8
Boccardi, M.Aff9, Aff10
Corre, J.
Drzezga, A.
Nordberg, A.Aff13, Aff14
Ossenkoppele, R.Aff4, Aff15
Zetterberg, H.Aff1, Aff16, Aff17, Aff18
Blennow, K.Aff1, Aff16
Frisoni, G. B.Aff9, Aff19
Garibotto, V.Aff7, Aff20
Hansson, O.Aff4, Aff18, Aff21, IDs0025902105253y_cor15
Pokaż więcej
Źródło:
European Journal of Nuclear Medicine and Molecular Imaging. 48(7):2140-2156
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pathophysiological subtypes of mild cognitive impairment due to Alzheimer's disease identified by CSF proteomics.
Autorzy:
Moutinho D; Faculty of Medicine, University of Lisbon, 1649-028, Lisbon, Portugal.
Mendes VM; CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal.; CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.
Caula A; LASIGE, Faculty of Sciences, University of Lisbon, 1649-028, Lisbon, Portugal.; Biocomputing Group, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Madeira SC; LASIGE, Faculty of Sciences, University of Lisbon, 1649-028, Lisbon, Portugal.
Baldeiras I; CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal.; CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Guerreiro M; Faculty of Medicine, University of Lisbon, 1649-028, Lisbon, Portugal.
Cardoso S; Faculty of Medicine, University of Lisbon, 1649-028, Lisbon, Portugal.
Gobom J; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, S-431 80, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, S-431 80, Mölndal, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, S-431 80, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, S-431 80, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.; Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin, University of Wisconsin-Madison, Madison, WI, 53792, USA.; UK Dementia Research Institute at UCL, London, WC1N 3BG, UK.
Santana I; CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal.; CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.; Department of Neurology, Hospital and University Centre of Coimbra, Coimbra, Portugal.
De Mendonça A; Faculty of Medicine, University of Lisbon, 1649-028, Lisbon, Portugal.
Aidos H; LASIGE, Faculty of Sciences, University of Lisbon, 1649-028, Lisbon, Portugal.
Manadas B; CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal. .; CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal. .
Pokaż więcej
Źródło:
Translational neurodegeneration [Transl Neurodegener] 2024 Apr 09; Vol. 13 (1), pp. 19. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:
Letter
MeSH Terms:
Alzheimer Disease*/complications
Alzheimer Disease*/diagnosis
Cognitive Dysfunction*/diagnosis
Humans ; Proteomics ; tau Proteins
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.
Autorzy:
Swift IJ; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Rademakers R; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.; VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Finch N; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Baker M; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Ghidoni R; Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, Brescia, Italy.
Benussi L; Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, Brescia, Italy.
Binetti G; MAC-Memory Clinic and Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, Brescia, Italy.
Rossi G; Unit of Neurology V and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Synofzik M; Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Wilke C; Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Mengel D; Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Graff C; Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, BioclinicumKarolinska Institutet, Solna, Sweden.; Unit for Hereditary Dementias, Theme Inflammation and Aging, Karolinska University Hospital, Solna, Sweden.
Takada LT; Department of Neurology, Hospital das Clinicas, University of São Paulo Medical School, São Paulo, Brazil.
Sánchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit, FRCB-IDIBAPS, Institut de Neurociències, Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona (UB), 08036, Barcelona, Spain.
Antonell A; Alzheimer's Disease and Other Cognitive Disorders Unit, FRCB-IDIBAPS, Institut de Neurociències, Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona (UB), 08036, Barcelona, Spain.
Galimberti D; Dept. of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Fenoglio C; Dept. of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Serpente M; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Arcaro M; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Schreiber S; Department of Neurology, Otto Von Guericke University, Magdeburg, Germany.
Vielhaber S; Department of Neurology, Otto Von Guericke University, Magdeburg, Germany.
Arndt P; Department of Neurology, Otto Von Guericke University, Magdeburg, Germany.
Santana I; Neurology Department, Centro Hospitalar E Universitário de Coimbra, Coimbra, Portugal.; Center for Neuroscience and Cell Biology, Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Almeida MR; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Moreno F; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain.
Barandiaran M; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain.
Gabilondo A; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain.
Stubert J; Department of Obstetrics and Gynecology, Rostock University Medical Center, Rostock, Germany.
Gómez-Tortosa E; Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain.
Agüero P; Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain.
Sainz MJ; Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain.
Gohda T; Department of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Murakoshi M; Department of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Kamei N; Department of Endocrinology and Metabolism, Hiroshima Red Cross Hospital & Atomicbomb Survivors Hospital, Hiroshima, Japan.; Institute for Clinical Research, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
Kittel-Schneider S; Department of Psychiatry, University College Cork, Cork, Ireland.; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital Würzburg, Würzburg, Germany.
Reif A; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital Frankfurt, Frankfurt, Germany.
Weigl J; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital Würzburg, Würzburg, Germany.; Department of Psychiatry, Hospital in Tauberbischofsheim, Tauberbischofsheim, Germany.
Jian J; University of Pennsylvania, Gene Therapy Program, Philadelphia, USA.
Liu C; Department of Orthopaedics & Rehabilitation, Yale University School of Medicine, New Haven, CT, USA.
Serrero G; A&G Pharmaceutical Inc, Columbia, MD, USA.; Program in Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Greither T; Center for Reproductive Medicine and Andrology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Theil G; Department of Urology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Lohmann E; Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany.
Gazzina S; Department of Neurological and Vision Sciences, Neurophysiology Unit, ASST SpedaliCivili, Brescia, Italy.
Bagnoli S; Department of Neurological and Psychiatric Sciences, University of Florence, Viale Morgagni, 85, 50134, Florence, Italy.
Coppola G; Department of Neurology, University of California, Los Angeles, California, USA.; Department of Psychiatry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, California, USA.
Bruni A; Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy.
Quante M; Department of Neonatology, Tuebingen University Hospital, Tuebingen, Germany.
Kiess W; Leipzig Research Center for Civilization Diseases - LIFE, University of Leipzig, Leipzig, Germany.; Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany.; Center of Pediatric Research (CPL), University of Leipzig, Leipzig, Germany.
Hiemisch A; Leipzig Research Center for Civilization Diseases - LIFE, University of Leipzig, Leipzig, Germany.; Center of Pediatric Research (CPL), University of Leipzig, Leipzig, Germany.
Jurkutat A; Leipzig Research Center for Civilization Diseases - LIFE, University of Leipzig, Leipzig, Germany.
Block MS; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Carlson AM; Department of Neurology, University of Colorado Anschutz Medical Campus, Denver, CO, USA.
Bråthen G; Department of Neurology and Clinical Neurophysiology, Trondheim University Hospital, Trondheim, Norway.; Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, NTNU. , Trondheim, Norway.
Sando SB; Department of Neurology and Clinical Neurophysiology, Trondheim University Hospital, Trondheim, Norway.; Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, NTNU. , Trondheim, Norway.
Grøntvedt GR; Department of Neurology and Clinical Neurophysiology, Trondheim University Hospital, Trondheim, Norway.; Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, NTNU. , Trondheim, Norway.
Lauridsen C; Department of Research, Trondheim University Hospital, Trondheim, Norway.
Heslegrave A; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.
Heller C; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Abel E; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.
Gómez-Núñez A; Alzheimer's Disease and Other Cognitive Disorders Unit, FRCB-IDIBAPS, Institut de Neurociències, Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona (UB), 08036, Barcelona, Spain.
Puey R; Alzheimer's Disease and Other Cognitive Disorders Unit, FRCB-IDIBAPS, Institut de Neurociències, Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona (UB), 08036, Barcelona, Spain.
Arighi A; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Rotondo E; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Jiskoot LC; Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, Netherlands.
Meeter LHH; Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, Netherlands.
Durães J; Neurology Department, Centro Hospitalar E Universitário de Coimbra, Coimbra, Portugal.
Lima M; Neurology Department, Centro Hospitalar E Universitário de Coimbra, Coimbra, Portugal.
Tábuas-Pereira M; Neurology Department, Centro Hospitalar E Universitário de Coimbra, Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Lemos J; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Boeve B; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Petersen RC; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Dickson DW; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Graff-Radford NR; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
LeBer I; Sorbonne UniversitéInserm U1127, CNRS UMR 7225, Institut du Cerveau Et La Moelle Épinière (ICM), AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
Sellami L; Sorbonne UniversitéInserm U1127, CNRS UMR 7225, Institut du Cerveau Et La Moelle Épinière (ICM), AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.; Centre de Référence Des Démences Rares Ou Précoces, IM2A, Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
Lamari F; UF de Biochimie Des Maladies Neurométaboliques Et Neurodégénératives, Service de Biochimie Métabolique, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
Clot F; UF de Neurogénétique Moléculaire Et Cellulaire, Département de Génétique, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, France.
Borroni B; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Cantoni V; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Rivolta J; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Lleó A; Neurology Department. Hospital Sant Pau, Memory Unit, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain.; Autonomous University of Barcelona, 08913, Barcelona, Spain.
Fortea J; Neurology Department. Hospital Sant Pau, Memory Unit, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain.; Autonomous University of Barcelona, 08913, Barcelona, Spain.
Alcolea D; Neurology Department. Hospital Sant Pau, Memory Unit, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain.; Autonomous University of Barcelona, 08913, Barcelona, Spain.
Illán-Gala I; Neurology Department. Hospital Sant Pau, Memory Unit, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain.; Autonomous University of Barcelona, 08913, Barcelona, Spain.
Andres-Cerezo L; Institute of Rheumatology, Na Slupi 4, 12850, Prague 2, Prague, Czech Republic.
Van Damme P; Laboratory of Neurobiology, Flanders Interuniversity Institute for Biotechnology, Katholieke Universiteit Leuven, Campus Gasthuisberg, 3000, Louvain, Belgium.
Clarimon J; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Memory Unit, Department of Neurology, Institut d'Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Steinacker P; Department of Neurology, Martin-Luther University Halle-Wittenberg, University Clinic Halle, Halle (Saale), Germany.
Feneberg E; Department of Neurology, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany.
Otto M; Department of Neurology, Martin-Luther University Halle-Wittenberg, University Clinic Halle, Halle (Saale), Germany.
van der Ende EL; Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, Netherlands.
van Swieten JC; Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, Netherlands.
Seelaar H; Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, Netherlands.
Zetterberg H; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at University College London, UCL Queen Square Institute of Neurology, University College London, London, UK.; Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, 43180, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.
Sogorb-Esteve A; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Rohrer JD; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. .
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Mar 28; Vol. 16 (1), pp. 66. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Frontotemporal Dementia*/genetics
Frontotemporal Dementia*/pathology
Male ; Humans ; Female ; Progranulins/genetics ; Intercellular Signaling Peptides and Proteins/genetics ; Virulence ; Mutation/genetics ; Membrane Proteins/genetics ; Nerve Tissue Proteins/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease.
Autorzy:
Lantero-Rodriguez J; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden. .
Salvadó G; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Snellman A; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden.; Turku PET Centre, University of Turku, Turku University Hospital, Turku, Finland.
Montoliu-Gaya L; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden.
Brum WS; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden.; Graduate Program in Biological Sciences: Biochemistry, Universidade Federal Do Rio Grande Do Sul (UFRGS), Porto Alegre, Brazil.
Benedet AL; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden.
Mattsson-Carlgren N; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.; Department of Neurology, Skåne University Hospital, Lund, Sweden.; Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
Tideman P; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.; Memory Clinic, Skåne University Hospital, 20502, Malmö, Sweden.
Janelidze S; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Palmqvist S; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Stomrud E; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.; Memory Clinic, Skåne University Hospital, 20502, Malmö, Sweden.
Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.; Department of Old Age Psychiatry, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.; NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation, London, UK.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, UK.; UK Dementia Research Institute, University College London, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Hansson O; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden. .; Memory Clinic, Skåne University Hospital, 20502, Malmö, Sweden. .
Pokaż więcej
Źródło:
Molecular neurodegeneration [Mol Neurodegener] 2024 Feb 17; Vol. 19 (1), pp. 19. Date of Electronic Publication: 2024 Feb 17.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*
Cognitive Dysfunction*
Humans ; tau Proteins ; Amyloid beta-Peptides ; Atrophy ; Biomarkers ; Disease Progression ; Positron-Emission Tomography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Inflammatory biomarkers for neurobehavioral dysregulation in former American football players: findings from the DIAGNOSE CTE Research Project.
Autorzy:
van Amerongen S; Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
Pulukuri SV; Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Tuz-Zahra F; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Tripodis Y; Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.; Boston University Alzheimer's Disease Research Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Cherry JD; Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; Boston University Alzheimer's Disease Research Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; VA Boston Healthcare System, U.S. Department of Veteran Affairs, Boston, MA, USA.; Department of Veterans Affairs Medical Center, Bedford, MA, USA.; Department of Pathology and Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Bernick C; Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA.
Geda YE; Department of Neurology and the Franke Global Neuroscience Education Center, Barrow Neurological Institute, Phoenix, AZ, USA.
Wethe JV; Department of Psychiatry and Psychology, Mayo Clinic School of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Katz DI; Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; Brain Injury Program, Encompass Health Braintree Rehabilitation Hospital, Braintree, MA, USA.
Alosco ML; Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; Boston University Alzheimer's Disease Research Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Adler CH; Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Balcer LJ; Departments of Neurology, Population Health and Ophthalmology, NYU Grossman School of Medicine, New York, NY, USA.
Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Institute of Psychiatry, Psychology and Neuroscience, King's College London, Maurice Wohl Institute Clinical Neuroscience Institute, London, UK.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Institute of Psychiatry, Psychology and Neuroscience, King's College London, Maurice Wohl Institute Clinical Neuroscience Institute, London, UK.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53792, USA.
Daneshvar DH; Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA.
Colasurdo EA; Veterans Affairs Northwest Mental Illness Research, Education, and Clinical Center, Seattle, WA, USA.
Iliff JJ; Veterans Affairs Northwest Mental Illness Research, Education, and Clinical Center, Seattle, WA, USA.; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Li G; Veterans Affairs Northwest Mental Illness Research, Education, and Clinical Center, Seattle, WA, USA.; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA.; Education, and Clinical Center, Veterans Affairs Puget Sound Health Care System Geriatric Research, Seattle, WA, USA.
Peskind ER; Veterans Affairs Northwest Mental Illness Research, Education, and Clinical Center, Seattle, WA, USA.; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Shenton ME; Psychiatry Neuroimaging Laboratory, Harvard Medical School, Departments of Psychiatry and Radiology, Brigham and Women's Hospital, Boston, MA, USA.
Reiman EM; Banner Alzheimer's Institute, University of Arizona, Arizona State University, Translational Genomics Research Institute, and Arizona Alzheimer's Consortium, Phoenix, AZ, USA.
Cummings JL; Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA.
Stern RA; Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. .; Boston University Alzheimer's Disease Research Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. .; Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. .; Departments of Neurosurgery, and Anatomy and Neurobiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. .
Pokaż więcej
Corporate Authors:
DIAGNOSE CTE Research Project Investigators
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2024 Feb 09; Vol. 21 (1), pp. 46. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Chronic Traumatic Encephalopathy*/pathology
Football*
Brain Injuries, Traumatic*
Humans ; Aged ; Middle Aged ; Interleukin-6 ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association of complement factor H Y402H gene polymorphism with Alzheimers diseasePlease cite this article as follows: Zetterberg M, Landgren S, Andersson ME, Palmér MS, Gustafson DR, Skoog I, Minthon L, Thelle DS, Wallin A, Bogdanovic N, Andreasen N, Blennow K, Zetterberg H. 2007. Association of Complement Factor H Y402H Gene Polymorphism With Alzheimers Disease. Am J Med Genet Part B 147B:720–726.
Autorzy:
Zetterberg, Madeleine
Landgren, Sara
Andersson, Malin E.
Palmér, Mona Seibt
Gustafson, Deborah R.
Skoog, Ingmar
Minthon, Lennart
Thelle, Dag S.
Wallin, Anders
Bogdanovic, Nenad
Andreasen, Niels
Blennow, Kaj
Zetterberg, Henrik
Pokaż więcej
Źródło:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics; September 2008, Vol. 147 Issue: 6 p720-726, 7p
Periodyk
Szczegóły
Tytuł:
A microglial activity state biomarker panel differentiates FTD-granulin and Alzheimer's disease patients from controls.
Autorzy:
Pesämaa I; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Graduate School of Systemic Neurosciences (GSN), Ludwig-Maximilians-University Munich, Munich, Germany.; Department of Psychiatry & Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Müller SA; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Neuroproteomics, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
Robinson S; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Graduate School of Systemic Neurosciences (GSN), Ludwig-Maximilians-University Munich, Munich, Germany.; Institute for Stroke and Dementia Research, University Hospital Munich, Ludwig-Maximilians- University Munich, Munich, Germany.
Darcher A; Epileptology, University Hospital Bonn, Bonn, Germany.
Paquet D; Institute for Stroke and Dementia Research, University Hospital Munich, Ludwig-Maximilians- University Munich, Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), Munich, Germany.
Zetterberg H; Department of Psychiatry & Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin, University of Wisconsin-Madison, Madison, WI, USA.
Lichtenthaler SF; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Neuroproteomics, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), Munich, Germany.
Haass C; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany. .; Munich Cluster for Systems Neurology (Synergy), Munich, Germany. .; Biomedical Centre (BMC), Faculty of Medicine, Ludwig-Maximilians-University Munich, Munich, Germany. .
Pokaż więcej
Źródło:
Molecular neurodegeneration [Mol Neurodegener] 2023 Sep 29; Vol. 18 (1), pp. 70. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*/metabolism
Frontotemporal Dementia*/genetics
Frontotemporal Dementia*/metabolism
Induced Pluripotent Stem Cells*/metabolism
Animals ; Humans ; Mice ; Amyloid beta-Peptides/metabolism ; Amyloidogenic Proteins/metabolism ; Biomarkers/metabolism ; Culture Media, Conditioned/pharmacology ; Granulins/metabolism ; Membrane Glycoproteins/genetics ; Mice, Knockout ; Microglia/metabolism ; Proteome ; Proteomics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19.
Autorzy:
Bark L; Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University Hospital, Uppsala University, Entr. 70, Floor 2, 75185, Uppsala, Sweden. .
Larsson IM; Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University Hospital, Uppsala University, Entr. 70, Floor 2, 75185, Uppsala, Sweden.
Wallin E; Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University Hospital, Uppsala University, Entr. 70, Floor 2, 75185, Uppsala, Sweden.
Simrén J; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.
Lipcsey M; Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University Hospital, Uppsala University, Entr. 70, Floor 2, 75185, Uppsala, Sweden.; Hedenstierna Laboratory, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Frithiof R; Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University Hospital, Uppsala University, Entr. 70, Floor 2, 75185, Uppsala, Sweden.
Rostami E; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Hultström M; Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University Hospital, Uppsala University, Entr. 70, Floor 2, 75185, Uppsala, Sweden.; Integrative Physiology, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, QC, Canada.; Lady Davis Institute of Medical Research, Jewish General Hospital, Montréal, QC, Canada.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 12; Vol. 13 (1), pp. 13144. Date of Electronic Publication: 2023 Aug 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/complications
Cognitive Dysfunction*/etiology
Male ; Humans ; Female ; Glial Fibrillary Acidic Protein ; Intermediate Filaments ; Neurofilament Proteins ; Biomarkers ; Central Nervous System ; Mental Fatigue
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Updating the study protocol: Insight 46 - a longitudinal neuroscience sub-study of the MRC National Survey of Health and Development - phases 2 and 3.
Autorzy:
Murray-Smith H; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK. h..
Barker S; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Barkhof F; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Centre for Medical Image Computing, University College London, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Barnes J; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Brown TM; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Captur G; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
R E Cartlidge M; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Cash DM; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.; Centre for Medical Image Computing, University College London, London, UK.
Coath W; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Davis D; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Dickson JC; Institute of Nuclear Medicine, University College London Hospitals, London, UK.
Groves J; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Hughes AD; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
James SN; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Keshavan A; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Keuss SE; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
King-Robson J; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Lu K; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Malone IB; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Nicholas JM; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Rapala A; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Scott CJ; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.; Institute of Nuclear Medicine, University College London Hospitals, London, UK.
Street R; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Sudre CH; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.; Centre for Medical Image Computing, University College London, London, UK.; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Thomas DL; Neuroradiological Academic Unit, UCL Queen Square Institute of Neurology, University College London, London, UK.
Wong A; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Wray S; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Zetterberg H; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.; UK Dementia Research Institute, University College London, London, UK.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Hong, Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
Chaturvedi N; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Fox NC; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Crutch SJ; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Richards M; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Schott JM; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2024 Jan 23; Vol. 24 (1), pp. 40. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article
MeSH Terms:
Dementia*
Aged ; Female ; Humans ; Male ; Aging ; Ambulatory Care ; Brain ; Observational Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Biomarkers for neurodegeneration impact cognitive function: a longitudinal 1-year case-control study of patients with bipolar disorder and healthy control individuals.
Autorzy:
Knorr U; Department Frederiksberg, Copenhagen Affective Disorder Research Center (CADIC), Psychiatric Center Copenhagen, Nordre Fasanvej 57-59, 2000, Frederiksberg, Denmark. .; Department of Psychology, University of Copenhagen, Copenhagen, Denmark. .
Simonsen AH; Danish Dementia Research Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Zetterberg H; Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, University College London, Queen Square, London, UK.; UK Dementia Research Institute University College London, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.
Blennow K; Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Willkan M; Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Forman J; Department of Psychology, University of Copenhagen, Copenhagen, Denmark.
Miskowiak K; Department Frederiksberg, Copenhagen Affective Disorder Research Center (CADIC), Psychiatric Center Copenhagen, Nordre Fasanvej 57-59, 2000, Frederiksberg, Denmark.; Department of Psychology, University of Copenhagen, Copenhagen, Denmark.
Hasselbalch SG; Danish Dementia Research Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Kessing LV; Department Frederiksberg, Copenhagen Affective Disorder Research Center (CADIC), Psychiatric Center Copenhagen, Nordre Fasanvej 57-59, 2000, Frederiksberg, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
International journal of bipolar disorders [Int J Bipolar Disord] 2024 Jan 16; Vol. 12 (1), pp. 2. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer's disease pathology.
Autorzy:
Therriault J; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Woo MS; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Neurology, Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, 20251, Germany.
Salvadó G; Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden.
Gobom J; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, S-431 80, Sweden.
Karikari TK; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, 15213, USA.
Janelidze S; Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden.
Servaes S; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Rahmouni N; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Tissot C; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.; Wallenberg Centre for Molecular Medicine, University of Gothenburg, Gothenburg, S-413 45, Sweden.; King's College London, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Institute Clinical Neuroscience Institute, London, SE5 9RT, UK.; NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, London, SE5 8AF, UK.
Benedet AL; Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.
Montoliu-Gaya L; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.
Macedo AC; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Lussier FZ; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, 15213, USA.
Stevenson J; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.
Vitali P; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Friese MA; Department of Neurology, Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, 20251, Germany.
Massarweh G; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Soucy JP; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Pascoal TA; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, 15213, USA.
Stomrud E; Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden.; Memory Clinic, Skåne University Hospital, Malmö, Sweden.
Palmqvist S; Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden.; Memory Clinic, Skåne University Hospital, Malmö, Sweden.
Mattsson-Carlgren N; Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden.; Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
Gauthier S; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, S-431 80, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 6BG, UK.; UK Dementia Research Institute at UCL, London, WC1N 6BG, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53792, USA.
Hansson O; Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden.; Memory Clinic, Skåne University Hospital, Malmö, Sweden.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, S-431 80, Sweden.
Rosa-Neto P; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada. .; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada. .
Pokaż więcej
Źródło:
Molecular neurodegeneration [Mol Neurodegener] 2024 Jan 07; Vol. 19 (1), pp. 2. Date of Electronic Publication: 2024 Jan 07.
Typ publikacji:
Journal Article
MeSH Terms:
Alzheimer Disease*/diagnosis
Humans ; Amyloidogenic Proteins ; Immunoassay ; Mass Spectrometry ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis.
Autorzy:
Gaetani L; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Bellomo G; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Di Sabatino E; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Sperandei S; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Mancini A; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Blennow K; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, 431 41 Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 431 41 Mölndal, Sweden.
Zetterberg H; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, 431 41 Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 431 41 Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.; UK Dementia Research Institute at UCL, London WC1E 6BT, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong 518172, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53792, USA.
Parnetti L; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Di Filippo M; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 21; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/diagnosis
Multiple Sclerosis, Relapsing-Remitting*/diagnosis
Humans ; Oligoclonal Bands ; Axons ; Biological Assay
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 21707

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies